Thursday, June 4, 2020
Immune responsive nanoparticles for COVID-19 vaccine delivery
"Our technology and approach are unique and has significant advantages over existing methodologies to develop COVID-19 vaccines in terms of added value and speed in the realization of health and socio-economic benefits. Specific benefits of our approach include easy nasal or oral administration, rapid cost-effective production, needle-free administration, potent intrinsic adjuvanticity and the increased safety and stability of OMV's which are stable for ultra-long periods when lyophilized". NewsMedical
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment